Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Jenkins

Showing results (591-600 of 799) with videos related to

Pageof 80
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridolK C Bible, S A Boerner, K Kirkland, et al.
BJU International|January 21, 2017
Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortalityKathryn L Pellegrini, Martin G Sanda, Dattatraya Patil, et al.
The Journal of Molecular Diagnostics : JMD|December 20, 2025
Development and Clinical Validation of OncCNV: A Pipeline for Comprehensive Genome-Wide Analysis of Oncogene Amplifications, Homozygous Deletions, and Biallelic Inactivation of Tumor Suppressor Genes Using the TruSight Oncology 500 KitStephanie A Smoley, Gopinath Sivasankaran, Mallika Gandham, et al.
Genes, Chromosomes & Cancer|June 23, 2009
Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell-mediated restoration of normal human chromosome 19Kristen L Drucker, Gaspar J Kitange, Thomas M Kollmeyer, et al.
Oncotarget|April 15, 2014
The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancerJohn R Prensner, Anirban Sahu, Matthew K Iyer, et al.
Neuro-Oncology|June 25, 2024
Genome-wide polygenic risk scores predict risk of glioma and molecular subtypesTaishi Nakase, Geno A Guerra, Quinn T Ostrom, et al.
Journal of Colloid and Interface Science|August 21, 2015
Highly stable multi-anchored magnetic nanoparticles for optical imaging within biofilmsR C Stone, B D Fellows, B Qi, et al.
Science (New York, N.Y.)|November 19, 2011
The hidden mass and large spatial extent of a post-starburst galaxy outflowTodd M Tripp, Joseph D Meiring, J Xavier Prochaska, et al.
Journal of the National Cancer Institute|August 16, 2001
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiformeJ S Smith, I Tachibana, S M Passe, et al.
The Prostate|August 4, 2019
A four-gene transcript score to predict metastatic-lethal progression in men treated for localized prostate cancer: Development and validation studiesAnqi Cheng, Shanshan Zhao, Liesel M FitzGerald, et al.
Pageof 80

Showing results (591-600 of 799) with videos related to

Sort By:
Pageof 80
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2000
Characterization of an ovarian carcinoma cell line resistant to cisplatin and flavopiridolK C Bible, S A Boerner, K Kirkland, et al.
BJU International|January 21, 2017
Evaluation of a 24-gene signature for prognosis of metastatic events and prostate cancer-specific mortalityKathryn L Pellegrini, Martin G Sanda, Dattatraya Patil, et al.
The Journal of Molecular Diagnostics : JMD|December 20, 2025
Development and Clinical Validation of OncCNV: A Pipeline for Comprehensive Genome-Wide Analysis of Oncogene Amplifications, Homozygous Deletions, and Biallelic Inactivation of Tumor Suppressor Genes Using the TruSight Oncology 500 KitStephanie A Smoley, Gopinath Sivasankaran, Mallika Gandham, et al.
Genes, Chromosomes & Cancer|June 23, 2009
Characterization and gene expression profiling in glioma cell lines with deletion of chromosome 19 before and after microcell-mediated restoration of normal human chromosome 19Kristen L Drucker, Gaspar J Kitange, Thomas M Kollmeyer, et al.
Oncotarget|April 15, 2014
The IncRNAs PCGEM1 and PRNCR1 are not implicated in castration resistant prostate cancerJohn R Prensner, Anirban Sahu, Matthew K Iyer, et al.
Neuro-Oncology|June 25, 2024
Genome-wide polygenic risk scores predict risk of glioma and molecular subtypesTaishi Nakase, Geno A Guerra, Quinn T Ostrom, et al.
Journal of Colloid and Interface Science|August 21, 2015
Highly stable multi-anchored magnetic nanoparticles for optical imaging within biofilmsR C Stone, B D Fellows, B Qi, et al.
Science (New York, N.Y.)|November 19, 2011
The hidden mass and large spatial extent of a post-starburst galaxy outflowTodd M Tripp, Joseph D Meiring, J Xavier Prochaska, et al.
Journal of the National Cancer Institute|August 16, 2001
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiformeJ S Smith, I Tachibana, S M Passe, et al.
The Prostate|August 4, 2019
A four-gene transcript score to predict metastatic-lethal progression in men treated for localized prostate cancer: Development and validation studiesAnqi Cheng, Shanshan Zhao, Liesel M FitzGerald, et al.
Pageof 80